Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma
Novo Nordisk A/S
Novo Nordisk A/S
University of Virginia
University of Wisconsin, Madison
Wake Forest University Health Sciences
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Wake Forest University Health Sciences
University of Louisville
Burzynski Research Institute
University of Southern California
Novartis
Novartis
Novartis
National Cancer Institute (NCI)
Case Comprehensive Cancer Center